XML 16 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Insider Trading Arrangements
 3 Months Ended
Mar. 31, 2024
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

Trading Arrangements

 

During our last fiscal quarter, our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated the contracts, instructions or written plans for the purchase or sale of our securities set forth in the table below.

 

 

 

 

Character of Trading Arrangement

 

 

Name and Title

Action

Date

Rule 10b5-1*

Non-Rule 10b5-1**

Total Shares to be Sold

Expiration Date

V. Bryan Lawlis,

Ph.D., Director

Adoption

February 14, 2024

X

 

35,0001

May 20, 2024

John A. Scarlett, M.D.,

Chairman of the Board, President and Chief Executive Officer

Adoption

February 20, 2024

X

 

600,0002

February 20, 2025

* Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.

** "Non-Rule 10b5-1 trading arrangement" as defined in Item 408(c) of Regulation S-K under the Exchange Act.

 

1 Includes up to 35,000 shares subject to stock options previously granted by Geron to Dr. Lawlis.

2 Includes up to 600,000 shares subject to stock options previously granted by Geron to Dr. Scarlett.

V. Bryan Lawlis, Ph.D.  
Trading Arrangements, by Individual  
Name V. Bryan Lawlis, Ph.D.
Title Director
Rule 10b5-1 Arrangement Adopted true
Non-Rule 10b5-1 Arrangement Adopted false
Adoption Date February 14, 2024
Rule 10b5-1 Arrangement Terminated true
Non-Rule 10b5-1 Arrangement Terminated false
Aggregate Available 35,000 [1]
Expiration Date May 20, 2024
John A. Scarlett, M.D.  
Trading Arrangements, by Individual  
Name John A. Scarlett, M.D.
Title Chairman of the Board, President and Chief Executive Officer
Rule 10b5-1 Arrangement Adopted true
Non-Rule 10b5-1 Arrangement Adopted false
Adoption Date February 20, 2024 [1]
Rule 10b5-1 Arrangement Terminated true
Non-Rule 10b5-1 Arrangement Terminated false
Aggregate Available 600,000 [2]
Expiration Date February 20, 2025
[1] Includes up to 35,000 shares subject to stock options previously granted by Geron to Dr. Lawlis.
[2] Includes up to 600,000 shares subject to stock options previously granted by Geron to Dr. Scarlett.